Health officials say a potential new weapon in the fight against melanoma is showing promising results. Moderna and Merck say ...

What makes a movie a summer movie? Is it the time of its release, or the way that it depicts the season itself? Or something ...

The rally was primarily driven by the strong late-stage trial of Moderna Inc.’s (NASDAQ:MRNA) intismeran autogene—an ...

Merck and Moderna’s success with a personalized cancer vaccine designed to keep melanoma at bay opens a ​new avenue of ...

Trump’s vaccine executive order may pressure Merck, GSK, and Sanofi pediatric vaccine sales, but analysts expect legal ...

The messenger RNA (mRNA) technology that became humanity's frontline defense during the COVID-19 pandemic has now crossed a ...

Tempus AI, Inc. made a timely move to acquire the Personalis cancer monitoring tests to advance AI-driven precision medicine.

The study also met a secondary goal of preventing cancer from spreading to different parts of the body.

It was given to patients with high-risk melanoma - the most aggressive form of skin cancer causing about 2,600 deaths a year ...

The S&P 500 (SP500) closed in the green on Friday, as Treasury yields held mostly steady and Bitcoin (BTC-USD) saw sharp swings. Nasdaq (COMP:IND) fell 2% for the week, while the Dow (DJI) declined 1.

Firstpost brings out an expert’s view on the growing link between obesity and cancer, how excess body fat may increase cancer ...

Several Section V athletes have committed to Division I football programs not too far from home, including Monroe's Brien ...